期刊文献+

FasL在川崎病患儿血清中的表达及意义 被引量:1

Expression and significance about FasL in serum of Kawasaki disease patient
下载PDF
导出
摘要 目的:对Fas/FasL途径的凋亡在川崎病发病中的情况进行研究。方法:采用双抗体夹心Elisa法测定正常健康对照组以及川崎病患儿血清中sFasL浓度。结果:和健康对照组儿童相比较,川崎病患儿急性期血清中sFasL浓度明显降低;经过治疗后,处于亚急性期的川崎病患儿血清中sFasL浓度较急性期明显升高;而在亚急性期,血清中sFasL浓度较健康对照组儿童相比无明显差异。结论:在川崎病的急性期Fas/FasL途径的凋亡减少,病情稳定后体内细胞凋亡现象趋于正常,提示在川崎病的发病机制中,细胞凋亡参与其中。 objective: To study the apoptosis about Fas/FasL channel in Kawasaki disease.Methods: To determine the concentration of sFasL in serum of normal group and Kawasaki disease patient with Elisa.Results: Compared with normal group,the concentration of sFasL in acute phase serum of Kawasaki disease patient is depression obviously.The concentration of sFasL in subacute stage serum of Kawasaki disease patient is advanced obviously compared with which in the acute phase.While in subacute stage,the difference is not obvious about the concentration of sFasL compared with normal group.Conclusion: The apoptosis about Fas/FasL channel is decreased at acute phase in Kawasaki disease patient.The apoptosis is tendency to normal when pathogenetic condition stable.We can make a conclusion that apoptosis participates the pathogenesy about Kawasaki disease.
作者 张小鸽 李喆
出处 《内蒙古中医药》 2011年第17期98-99,共2页 Inner Mongolia Journal of Traditional Chinese Medicine
关键词 细胞凋亡 川崎病 apoptosis Kawasaki disease
  • 相关文献

参考文献5

二级参考文献27

  • 1石英(综述),黄国良(审校).Fas/FasL途径在Graves病发病机制中的作用[J].国外医学(内分泌学分册),2005,25(1):48-50. 被引量:12
  • 2陈新民.川崎病的诊断进展[J].中国全科医学,2007,10(5):383-384. 被引量:33
  • 3Cheng J, Zhou T, Lin C. Protection from Fas-mediated apoptosis by soluble form of molecule. Science, 1994, 263: 1759-1762.
  • 4Amasali Y, Kobayash S, Takeda T, et al. Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematcsus (SLE): a possible mechanism for lymphopenia. Clin Exp Immunol, 1995, 99: 245-250.
  • 5Hara H, Morita Y, Sato R, et al. Circulating nuclear matrix protein in Graves' disease. Endocr J, 2002, 49: 343-347.
  • 6诸福棠.实用儿科学.7版,北京:人民卫生出版社,2002:1204—1205
  • 7Hiromatsu Y, Bednarczuk T, Soyejima E, et al. Increased serum soluble Fas in patients with Graves' disease. Thyroid,1999,9:341-345.
  • 8Wang CY, Zhong WB, Chang TC,et al. Circulating soluble Fas ligand correlates with disease activity in Graves' hyperthyroidism. Metabolism,2002,51: 769-773.
  • 9Hiromatsu Y, Hoshino T, Yagita H,et al. Functional Fas ligand expression in thyrocytes from patients with Graves' disease. J Clin Endocrinol Metab, 1999,84:2896-2902.
  • 10Sera N, Kawakami A, Nakashima T,et al. Fas/FasL mediated apoptosis of thyrocytes in Graves' disease. Clin Exp Immunol,2001,124:197-207.

共引文献100

同被引文献14

  • 1Uehara R, Belay ED. Epidemiology of Kawasaki disease in asia, europe, and the united states. J Epidemiol, 2012,22 (2) :79-85.
  • 2Ayusawa M, Sonobe T, Uemura S, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int, 2005,47(2) :232-234.
  • 3Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovas- cular disease in the young, American Heart Association. Circulation, 2004,110 (17) :274-7-2771.
  • 4Straface E, Gambardella L, Metere A, et al. Oxidative stress and defective platelet apoptosis in naive patients with Kawasaki disease. Biochem Biophys Res Commun, 2010,392 ( 3 ) :426-430.
  • 5Tsujimoto H, Takeshita S, Nakatani K, et al. Delayed apoptosis of circulating neutrophils in Kawasaki disease. Clin Exp Immunol, 2001,126(2) :355-364.
  • 6Galeotti C, Bayry J, Kone-Pant I, et al. Kawasaki disease : aetiopathogenesis and therapeutic utility of intravenous immunoglobulin. Autoimmun Rev, 2010,9(6) :441-448.
  • 7Tawfik DS, Cowan KR, Walsh AM, et al. Exogenous immunoglobulin downregulates T-cell receptor signaling and cytokine production. Pediatr Allergy Immunol, 2012,23 ( 1 ) :88-95.
  • 8von Gunten S, Simon HU. Cell death modulation by intravenous immunoglobulin. J Clin Immunol, 2010,30 Suppl 1 :S24-S30.
  • 9Tsujimoto H, Takeshita S, Nakatani K, et al. Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease. Clin Immunol, 2002,103(2) :161-168.
  • 10杨永生,徐金华.重症大疱性药疹免疫机制及免疫治疗进展[J].国际皮肤性病学杂志,2008,34(2):78-80. 被引量:1

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部